This content is available for reuse with permission. If you are interested in reusing this content, please email newsroom@davita.com.
A large-scale, longitudinal study from DaVita Clinical Research presented at ASN Kidney Week bridges a vital clinical trial gap, examining GLP-1 use and clinical outcomes in home dialysis. Key Takeaways Closing a critical evidence gap: While major clinical trials have previously excluded individuals requiring dialysis, this study of 5,900 DaVita patients provides real-world data supporting […]
“Learning I had kidney disease was a big turning point,” Nobert Mike remembers. Nobert shares that he had a hard life growing up: “I lost a lot of good people, lost a lot of good things in my life.” He, like many other people he knows living on Navajo Nation, struggled with alcohol addiction. Eventually, […]
More than one in four deceased-donor kidneys goes unused each year.1One of the reasons for this is the uncertainty around the quality of the kidney. Clinicians often cannot be sure whether an organ that looks marginal will actually work once transplanted. Research from Johns Hopkins Medicine suggests a better answer may already be available, and […]
At a Glance While a kidney transplant is the most clinically- and cost-effective treatment for end stage kidney disease (ESKD), systemic barriers and social determinants of health frequently leave underserved communities behind. Accelerating the path to transplant can help close persistent gaps in chronic disease management while also reducing the time patients spend on dialysis. […]
As DaVita expands access to Expanded hemodialysis (HD), some patients who have recently started the treatment have shared positive personal experiences, including changes in how they feel day to day. These individual stories reflect patients’ perspectives and experiences and should not be interpreted as evidence of clinical outcomes for all patients. Real-World Patient Experiences The […]